INTEC PHARMA LTD. Pre-Tax Income
INTEC PHARMA LTD. reported Pre-Tax Income of -$4.21 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2021-05-17
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-03-31 was -$4.21M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-12-31 was -$3.60M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-09-30 was -$3.70M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-06-30 was -$2.90M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$14.00M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$46.96M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$43.44M.
- INTEC PHARMA LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2017 was -$28.88M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$4.21M 10-Q · filed 2021-05-17 | -$7.80M derived: sum of 2 quarters · filed 2021-05-17 | -$11.50M derived: sum of 3 quarters · filed 2021-05-17 | -$14.40M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$7.29M derived: sum of 2 quarters · filed 2021-03-16 | -$10.20M derived: sum of 3 quarters · filed 2021-03-16 | -$14.00M 10-K · filed 2021-03-16 |
| 2020-09-30 | -$3.70M 10-Q · filed 2020-11-05 | -$6.60M derived: sum of 2 quarters · filed 2020-11-05 | -$10.41M 10-Q · filed 2020-11-05 | -$16.43M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | -$2.90M 10-Q · filed 2020-08-05 | -$6.71M 10-Q · filed 2020-08-05 | -$12.73M derived: sum of 3 quarters · filed 2021-05-17 | -$33.08M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | -$3.81M 10-Q · filed 2021-05-17 | -$9.83M derived: sum of 2 quarters · filed 2021-05-17 | -$30.18M derived: sum of 3 quarters · filed 2021-05-17 | -$40.15M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$26.37M derived: sum of 2 quarters · filed 2021-03-16 | -$36.34M derived: sum of 3 quarters · filed 2021-03-16 | -$46.96M 10-K · filed 2021-03-16 |
| 2019-09-30 | -$20.35M 10-Q · filed 2020-11-05 | -$30.32M derived: sum of 2 quarters · filed 2020-11-05 | -$40.94M 10-Q · filed 2020-11-05 | -$53.49M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$9.97M 10-Q · filed 2020-08-05 | -$20.59M 10-Q · filed 2020-08-05 | -$33.14M derived: sum of 3 quarters · filed 2020-08-05 | -$42.48M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$10.62M 10-Q · filed 2020-05-11 | -$23.17M derived: sum of 2 quarters · filed 2020-05-11 | -$32.51M derived: sum of 3 quarters · filed 2020-05-11 | -$43.40M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$12.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$21.89M derived: sum of 2 quarters · filed 2020-03-13 | -$32.77M derived: sum of 3 quarters · filed 2020-03-13 | -$43.44M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$9.34M 10-Q · filed 2019-11-12 | -$20.23M derived: sum of 2 quarters · filed 2019-11-12 | -$30.89M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$10.89M 10-Q · filed 2019-08-09 | -$21.55M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$10.67M 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | -$28.88M 10-K · filed 2019-02-27 |